CERo Therapeutics Holdings Inc [NASDAQ: CERO] gained 188.73% on the last trading session, reaching $19.83 price per share at the time.
If compared to the average trading volume of 104.26K shares, CERO reached a trading volume of 57189993 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about CERo Therapeutics Holdings Inc [CERO]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CERO shares is $140.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CERO stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Trading performance analysis for CERO stock
CERo Therapeutics Holdings Inc [CERO] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 169.80. With this latest performance, CERO shares gained by 69.49% in over the last four-week period, additionally sinking by -85.75% over the last 6 months – not to mention a drop of -97.24% in the past year of trading.
#####
CERo Therapeutics Holdings Inc [CERO]: A deeper dive into fundamental analysis
CERo Therapeutics Holdings Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.73 and a Current Ratio set at 0.73.
CERo Therapeutics Holdings Inc [CERO]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CERO. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for CERo Therapeutics Holdings Inc go to 57.21%.
